Mounjaro Kwikpen (10mg)

Mounjaro KwikPen is a pre-filled injection pen that delivers tirzepatide, a medication used to treat type 2 diabetes and also being studied and used off-label for weight loss.

What is Mounjaro?

• Generic name: Tirzepatide

• Brand: Mounjaro

• Made by: Eli Lilly

• Type: Dual GIP and GLP-1 receptor agonist

• Form: Injectable (once a week via the KwikPen)

How Does Mounjaro Work?

Mounjaro:

• Improves insulin sensitivity and reduces blood sugar

• Slows gastric emptying, which reduces appetite

• Promotes weight loss

• Targets two gut hormones (GLP-1 and GIP), unlike Ozempic (which targets only GLP-1)

What is the KwikPen?

• A disposable, pre-filled injection pen

• Used once per week, subcutaneously (under the skin)

• Comes in multiple strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg

• Designed for easy self-injection (no mixing required)

Used For:

1. FDA-approved for:

   • Type 2 diabetes (blood sugar control)

2. Off-label (but common) use:

   • Weight loss (some trials show higher weight loss than Ozempic)

Possible Side Effects:

• Nausea, vomiting, diarrhea

• Constipation

• Decreased appetite

• Fatigue

• Rare but serious: pancreatitis, gallbladder issues

Avoid Mounjaro if you have:

• History of medullary thyroid cancer or MEN2

• Type 1 diabetes

• Severe gastrointestinal disease (like gastroparesis)

Effectiveness:

• In studies, users lost up to 15–22% of body weight over time.

• Also highly effective at lowering A1C in diabetes.